De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology
Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.